Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes
about
Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)[Benign prostatic hyperplasia and urolithiasis].Practice patterns of recently fellowship-trained reconstructive urologists.Lower urinary tract symptoms and diet quality: findings from the 2000-2001 National Health and Nutrition Examination Survey.Testosterone replacement therapy and voiding dysfunction.Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.The link between benign prostatic hyperplasia and prostate cancer.Benign prostatic hyperplasia: a new metabolic disease?Testosterone Replacement Therapy on the Natural History of Prostate Disease.Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Increased susceptibility of estrogen-induced bladder outlet obstruction in a novel mouse model.Office evaluation of male patients with lower urinary tract symptoms.The “Aging Males’ Symptoms” Scale (AMS): predictive value for lowered circulating androgens
P2860
Q24289188-DE5AD853-3CFA-4118-BB6F-C1473D408687Q33991602-87FC53C2-8CF6-4C2F-BC97-0A26EE6CA56EQ36291193-E19C3968-652E-4F2C-AD8E-E034A419971DQ36590762-0181A079-B75E-4FC0-880A-FC66646F17E9Q37531050-50E4FF7A-ECB9-4A5B-B337-C639E250D87FQ37618958-137DA0DA-4220-48BE-8639-0FC2ECF0E2B8Q37644679-66A41234-544B-4766-9374-15AABED1910AQ38061029-98791FF2-991A-47D5-A47D-6ED4FFE0577BQ38181426-0EB82E62-F64A-4A5F-9429-9377BB70F5B2Q38528388-C3586F97-B685-4C94-B563-1406DF6C7151Q38805656-1B2D3974-02E6-48C0-A735-714CFA45E783Q39095837-A33CE4A6-F109-4EE0-A748-764B30FA827FQ42473275-550AAF26-1495-45B7-ABFA-112230BD5E23Q51317315-8ADDEAB5-AF63-4939-A9FB-622A22699025Q58128897-8172BA2F-D3B3-46F4-A530-0D9403B16BA1
P2860
Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Associations between longitudi ...... es in benign urologic outcomes
@ast
Associations between longitudi ...... es in benign urologic outcomes
@en
Associations between longitudi ...... es in benign urologic outcomes
@nl
type
label
Associations between longitudi ...... es in benign urologic outcomes
@ast
Associations between longitudi ...... es in benign urologic outcomes
@en
Associations between longitudi ...... es in benign urologic outcomes
@nl
prefLabel
Associations between longitudi ...... es in benign urologic outcomes
@ast
Associations between longitudi ...... es in benign urologic outcomes
@en
Associations between longitudi ...... es in benign urologic outcomes
@nl
P2093
P2860
P356
P1476
Associations between longitudi ...... es in benign urologic outcomes
@en
P2093
Cynthia J Girman
Debra J Jacobson
George G Klee
Jennifer L St Sauver
Michael M Lieber
Michaela E McGree
P2860
P304
P356
10.1093/AJE/KWQ438
P407
P577
2011-03-02T00:00:00Z